Trending News
News
News
CRISPR Reveals the Sugary Secrets of the Cancer-related Notch Protein
New research shows that the fucose and glucose modifications serve as quality-control markers that allow Notch to be transported to its final destination in the cell membrane.
News
Metabolic Classification of Human Hepatoblastoma Uncovered
EPFL scientists have now found metabolic differences between hepatoblastoma subtypes, and identified several biomarkers that can help obtain more accurate subtyping of the disease.
News
Endomag Receives CE Mark Approval for Magseed Breast Cancer Localisation Technology
Endomag can now use Magseed, an accurate marker for surgeons to use during breast cancer removal surgery.
News
‘Epigenetic’ Changes from Cigarette Smoke May be First Step in Lung Cancer Development
Preliminary evidence in laboratory-grown, human airway cells indicate that a condensed form of cigarette smoke triggers so-called “epigenetic” changes in the cells consistent with the earliest steps toward lung cancer development.
News
Forgoing Conventional Cancer Treatments for Alternative Medicine Increases Risk of Death
In a large study, patients with nonmetastatic breast, lung, or colorectal cancer who chose alternative therapies had substantially worse survival than patients who received conventional cancer treatments.
News
Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research in Europe
Thermo Fisher Scientific expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays in cancer research.
News
Centauri Therapeutics Receives Innovate UK Biomedical Catalyst Award
Centauri Therapeutics has been awarded £945,000 to generate a clinical candidate drug against Gram-negative bacteria.
News
Institute of Pathology Joins Thermo Fisher Scientific to Drive Oncology Companion Diagnostic Development
Institute of Pathology Heidelberg collaborates with Thermo Fisher Scientific to establish the Next Generation Sequencing Companion Dx Center of Excellence Program in Europe.
News
Promising Response Rates Support Development of Pembrolizumab
Pembrolizumab has shown a promising response rate in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented today at the ESMO 2017 Congress in Madrid.
News
Astrocytoma Cell Repair Genes Linked to Brain Cancer Aggressiveness
The study focused on glioblastomas, the most aggressive of the four subtypes into which the World Health Organization (WHO) classifies astrocytomas: patients with this type of tumor survive 14 months on average.
Advertisement